Picture of Humanigen logo

HGENQ — Humanigen News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Humanigen Confirms Notice Received From NIAID That They Have Completed Database Lock For Big Effect Trial Of Lenzilumab

June 30 (Reuters) - Humanigen Inc  HGEN.O :
    * HUMANIGEN - CONFIRMS NOTICE RECEIVED FROM NIAID THAT THEY
HAVE
COMPLETED DATABASE LOCK FOR BIG EFFECT TRIAL OF LENZILUMAB
    * HUMANIGEN INC - NIH/NIAID HAS CLEANED AND LOCKED BLINDED
DATA IN
STUDY
    * HUMANIGEN INC - EXPECTS TO RECEIVE TOPLINE RESULTS FROM
NIH/NIAID IN JULY

Source text for Eikon:  ID:nBw6WcmqQa 
Further company coverage:  HGEN.O

Recent news on Humanigen

See all news